Clinical Trial Update: Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating the combination of cisplatin and epinephrine in patients with recurrent or refractory he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• EPINEPHRINE (EPINEPHRINE)

Snippet

Sponsor: Matrix Pharmaceutical | Conditions: Head and Neck Cancer | Phase 3 | Status: UNKNOWN